Literature DB >> 9571170

Butein, a specific protein tyrosine kinase inhibitor.

E B Yang1, K Zhang, L Y Cheng, P Mack.   

Abstract

Butein, a plant polyphenol, was shown to be a specific protein tyrosine kinase inhibitor. This compound inhibited not only the epidermal growth factor (EGF)-stimulated auto-phosphotyrosine level of EGF receptor in HepG2 cells but also tyrosine-specific protein kinase activities of EGF receptor (IC50 = 65 microM) and p60c-src (IC50 = 65 microM) in vitro. The inhibition was competitive to ATP and non-competitive to the phosphate acceptor, poly (Glu, Ala, Tyr) 6:3:1 for EGF receptor tyrosine kinase. In contrast, butein non-significantly inhibited the activities of serine- and threonine-specific protein kinases, such as protein kinase C (PKC) and cAMP-dependent protein kinase (PKA).

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9571170     DOI: 10.1006/bbrc.1998.8452

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

Review 1.  The role of chalcones in suppression of NF-κB-mediated inflammation and cancer.

Authors:  Vivek R Yadav; Sahdeo Prasad; Bokyung Sung; Bharat B Aggarwal
Journal:  Int Immunopharmacol       Date:  2010-12-22       Impact factor: 4.932

Review 2.  Chalcone: A Privileged Structure in Medicinal Chemistry.

Authors:  Chunlin Zhuang; Wen Zhang; Chunquan Sheng; Wannian Zhang; Chengguo Xing; Zhenyuan Miao
Journal:  Chem Rev       Date:  2017-05-10       Impact factor: 60.622

3.  Butein induces apoptosis and inhibits prostate tumor growth in vitro and in vivo.

Authors:  Naghma Khan; Vaqar M Adhami; Farrukh Afaq; Hasan Mukhtar
Journal:  Antioxid Redox Signal       Date:  2012-01-16       Impact factor: 8.401

4.  Tannic acid down-regulates the angiotensin type 1 receptor through a MAPK-dependent mechanism.

Authors:  Rekha Yesudas; Upendra Gumaste; Russell Snyder; Thomas Thekkumkara
Journal:  Mol Endocrinol       Date:  2012-02-09

Review 5.  Molecular targeted approaches to cancer therapy and prevention using chalcones.

Authors:  Danielle D Jandial; Christopher A Blair; Saiyang Zhang; Lauren S Krill; Yan-Bing Zhang; Xiaolin Zi
Journal:  Curr Cancer Drug Targets       Date:  2014       Impact factor: 3.428

6.  Synthesis and biological evaluation of chalcone-linked pyrazolo[1,5-a]pyrimidines as potential anticancer agents.

Authors:  Chandrakant Bagul; Garikapati Koteswara Rao; Venkata Krishna Kanth Makani; Jaki R Tamboli; Manika Pal-Bhadra; Ahmed Kamal
Journal:  Medchemcomm       Date:  2017-07-13       Impact factor: 3.597

Review 7.  Molecular targets and anticancer activity of quinoline-chalcone hybrids: literature review.

Authors:  Mamdouh F A Mohamed; Gamal El-Din A Abuo-Rahma
Journal:  RSC Adv       Date:  2020-08-21       Impact factor: 4.036

8.  Anti-cancer potential of flavonoids: recent trends and future perspectives.

Authors:  Priya Batra; Anil K Sharma
Journal:  3 Biotech       Date:  2013-02-12       Impact factor: 2.406

9.  The chalcone butein from Rhus verniciflua Stokes inhibits clonogenic growth of human breast cancer cells co-cultured with fibroblasts.

Authors:  Michael Samoszuk; Jenny Tan; Guillaume Chorn
Journal:  BMC Complement Altern Med       Date:  2005-03-09       Impact factor: 3.659

10.  Butein suppresses breast cancer growth by reducing a production of intracellular reactive oxygen species.

Authors:  Sung-Gook Cho; Sang-Mi Woo; Seong-Gyu Ko
Journal:  J Exp Clin Cancer Res       Date:  2014-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.